Organization · Venture Capital
Point Sur Investors
Point Sur Investors LLC is an independent investment advisor based in Palo Alto, California, specializing in long-biased investments in publicly traded biopharmaceutical companies. The firm focuses on companies developing medicines that have entered human clinical trials.
Overview
What Point Sur Investors does
What Point Sur Investors is
Point Sur Investors LLC is an independent investment advisor based in Palo Alto, California, specializing in long-biased investments in publicly traded biopharmaceutical companies. The firm focuses on companies developing medicines that have entered human clinical trials.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find Point Sur Investors elsewhere
Open the official website or a supported primary organization account.
Capability profile
Point Sur Investors as a funder
Investment thesis
Point Sur Investors focuses on long-biased investments in the biotech sector, targeting small to mid-sized publicly traded biopharmaceutical companies that are developing innovative medicines with the potential to advance standard care.
Focus narrative
PSI's investment strategy is centered on identifying and investing in biotech companies that are developing innovative therapies with the potential to significantly improve patient care. The firm typically engages in public equity investments but also participates in late-stage private rounds, particularly in crossover investments.
Value beyond capital
Point Sur Investors adds value to its portfolio companies through strategic insights and support from its experienced management team, leveraging their expertise in biotech to guide companies through the complexities of drug development and commercialization.
Focus and fit
- Stages
- Series A · Growth Equity
- Regions
- North America
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Notable portfolio activity includes investments in Biomea Fusion, where PSI participated in a $56M Series A financing, as well as holdings in Dyne Therapeutics and PTC Therapeutics, reflecting a focus on companies with promising clinical advancements.
Common questions
What to know about Point Sur Investors
Upseed classifies Point Sur Investors under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.